What is it? Why is it important?

Study data is any information that is collected or generated during study conduct and needed to answer its primary- and secondary research questions (i.e. study outcome / endpoint).  Any data collected during the study must be specified and documented in the study protocol.

 

For the statistical analysis, only digital data is used. Therefore, and prior to the analysis, collected non-digital data formats are collected and translated into some type of coded format (e.g. visual imaging, laboratory notebooks, participant diaries, interviews)

 

Typical data collected in a study are:

  • Descriptive data (e.g. age, gender, demographics)
  • Study relevant data needed to answer the research question(s) (e.g. disease characteristics, intervention efficacy, observational data)
  • Safety data, with the collection of adverse events experienced by study participants  during study conduct

What do I need to do?

As a SP-INV, list data needed to answer the research question(s) in the study protocol, CRF, Data management plan (DMP), and Statistical analysis plan. Submit all planed data, to be collected during study conduct, to theEthics Committee for approval

 

The excessive collection and documentation of data not needed to answer the study question(s)

 

Prior to collecting any data from study participants requires that they consent (ICF) to study participation. Health related data is considered sensitive data. Thus, special protection. handling and management are required to ensure the identity of study participants.

Where can I get help?

Your local Research Support Centre can assist you with experienced staff regarding this topic

  • Basel, Departement Klinische Forschung (DKF), dkf.unibas.ch

  • Lugano, Clinical Trials Unit (CTU-EOC), ctueoc.ch

  • Bern, Department of Clinical Research (DCR), dcr.unibe.ch

  • Geneva, Clinical Research Center (CRC), crc.hug.ch

  • Lausanne, Clinical Research Center (CRC), chuv.ch

  • St. Gallen, Clinical Trials Unit (CTU), h-och.ch

  • Zürich, Clinical Trials Center (CTC), usz.ch

References

ICH GCP E6(R3) – see in particular principle and guidelines

  • Principle 1: Requirements for study conduct
  • 2.12 Records
  • 3.1 Trial Design
  • 3.16.1 (d) Fit for purpose data capture
  • 4.2.1 Data capture
  • B.14 Data Handling and Record Keeping
  • C.3 Essentiality of Trial Records

ICH E8(R1) – see in particular guideline

  • 5.7 Study Data
  • 6.1.3 Data Management

Swiss Law

ClinO – see in particular article

  • Art. 4 Scientific quality
Abbreviations
  • ClinO – Clinical Trials Ordinance
  • CRF – Case Report Form
  • CTU – Clinical Trials Unit
  • ICF – Informed Consent Form
  • ICH – International Council for Harmonisation
  • ICH GCP – International Council for Harmonisation - Good Clinical Practice
  • SP-INV – Sponsor Investigator
Basic ↦ Data Management ↦ Study Database ↦ Study Data
Study
Basic

Provides some background knowledge and basic definitions

Basic Monitoring
Concept

Starts with a study idea

Ends after having assessed and evaluated study feasibility

Concept Statistic Methodology
Concept Drug or Device
Development

Starts with confidence that the study is feasible

Ends after having received ethics and regulatory approval

Development Drug or Device
Set-Up

Starts with ethics and regulatory approval

Ends after successful study initiation

Set-Up Ethics and Laws
Set-Up Statistic Methodology
Set-Up Quality and Risk
Set-Up Drug or Device
Conduct

Starts with participant recruitment

Ends after the last participant has completed the last study visit

Conduct Statistic Methodology
Conduct Drug or Device
Completion

Starts with last study visit completed

Ends after study publication and archiving

Completion Drug or Device
Current Path (click to copy): Basic ↦ Data Management ↦ Study Database ↦ Study Data